The post hoc analysis in this study highlighted that tirzepatide was well tolerated and had a favorable benefit/risk profile in East Asian participants over a range of baseline BMI values and ages, and suggested that lower doses may be beneficial for older patients and those with lower BMI, underscoring the need for personalized treatment
The concentrations of carbachol, PIA, nifedipine, and ryanodine were based on our own work (Neumann et al
Research on GLP-1 receptor agonists more broadly shows that these medications can reduce inflammatory cytokines and improve endothelial function, both of which support better fluid distribution and reduced edema risk
Improved Metabolic Health: Beyond weight loss, semaglutide helps improve cholesterol levels, reduce blood pressure, and enhance overall metabolic health
Triglycerides move more than LDL
Will my insurance cover tirzepatide for PCOS